Based on these results, we can reasonably speculate that hepatic Rspo3 induction locally diminishes obesity-related fatty liver progression by balancing the degrees of lipogenesis, lipid oxidation, and glucose utilization (gluconeogenesis, glycolysis, and glycogenesis) in the liver (S12C Fig). Here, RSPO3 is linked to obesity due to melanocortin 4 receptor deficiency.